Johnson & Johnson (NYSE:JNJ) recently said its medical device business paid an undisclosed amount to acquire French robot-assisted surgery company Orthotaxy. Founded in 2009, Orthotaxy’s proprietary technology is currently in early-stage development for total and partial knee replacements. J&J plans to expand Orthotaxy’s technology into other orthopedic surgeries as part of its bid to create a new…